Integromics Appoints Dr. Michael J. McManus as President & CEO
Integromics announced that it has selected Dr. Michael J. McManus as President & CEO. Dr. McManus will lead the company’s efforts to expand in the world market, with a particular focus on proteomics and on further developing Integromics’ activity in the U.S. and Asian markets.
Dr. McManus, 52, has over 25 years of scientific software and business experience, including operational management, business development, strategic planning, research and development, product marketing and product management expertise. His scientific background spans chemistry (including synthetic organic, computational, cheminformatics, and polymer chemistry sub-disciplines), bioinformatics, data mining and visualization. Dr. McManus received his Ph.D. in synthetic organic chemistry from the Massachusetts Institute of Technology. He received his B.S. in chemistry, summa cum laude, from the University of Massachusetts, Amherst.
Prior to joining Integromics, Dr. McManus led GenomeQuest’s corporate marketing, strategic alliances, product marketing and product development efforts. Before joining GenomeQuest, Dr. McManus served as Vice President of Business Development for the BioSciences Group of Fujitsu Computer Systems, where he set up and initiated the Group's U.S. operations and as Executive VP and COO of AnVil Informatics, Inc. Prior to AnVil, he served as Vice President of Marketing and Business Development at CambridgeSoft Corporation.
Other news from the department people
